TABLE 1

Patient and Scan Characteristics

	BCR^* (n = 24)		Primary staging^† (n = 5)
Characteristic	Median	Range	Median	Range
Age (y)	67	61–77	63	55–69
PSA (ng/mL)	0.7	0.4–1.9	8.7	7.2–26.8
Gleason score	7	6–9	7	7–8
Tumor stage	3a	2a–4	3a	—
Injected dose (MBq)	314.3	257.7–328.6	318.8	299.0–325.9
Uptake time (min)	120	99–142	123	117–164

↵* Inclusion period: November 2017–October 2018.
↵† Inclusion period: November 2017–February 2018.
Data are based on prostatectomy specimens.